ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Lone Peak Psychiatry Leads the Way in Ketamine Therapy, Offering Hope to Patients

Murray, Utah (Newsworthy.ai) Saturday Dec 23, 2023 @ 7:00 AM Eastern —

Ketamine, a psychedelic medication traditionally used as an anesthetic for over five decades, has captured the attention of researchers in recent years. Numerous studies have shown promising results on its effectiveness in treating depression, suicidal thoughts, anxiety, PTSD, OCD, and eating disorders. Lone Peak Psychiatry is at the forefront of offering this innovative solution to patients, providing them with a renewed sense of hope and relief. The clinic offers a game-changing approach to patients seeking effective alternatives to traditional medication and psychotherapy.

Dr. John Smith, a renowned psychiatrist and founder of Lone Peak Psychiatry, emphasizes the clinic's commitment to delivering exceptional care through their Ketamine Assisted Psychotherapy (KAP). Dr. Smith states, "We strongly believe in the potential of ketamine therapy to offer breakthrough results for our patients. Our providers undergo specialized training in administering ketamine and are dedicated to creating a safe and supportive environment for our patients throughout the entire treatment journey."

Patients at Lone Peak Psychiatry can expect a comfortable and personalized experience. The treatment involves a convenient intramuscular shot in the patient's arm, with compassionate and specially trained providers closely monitoring them. In a private room furnished with a comfortable recliner and soothing music, patients are offered an atmosphere designed to enhance their treatment session.

In addition to the treatment itself, Lone Peak Psychiatry offers comprehensive guidance and integration support before and after the ketamine therapy. This holistic approach ensures that patients receive the necessary tools and resources to maximize the benefits of their treatment.

As pioneers in the field, Lone Peak Psychiatry also plays an instrumental role in educating other psychiatric providers in the community. They offer training programs to help expand the understanding and application of ketamine therapy, ultimately benefiting a greater number of individuals struggling with mental health conditions.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Lone Peak Psychiatry Leads the Way in Ketamine Therapy, Offering Hope to Patients.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.